Clinical Decision Support for SGLT2i After AKI in Type 2 Diabetes

Inclusion Criteria for Providers and Pharmacists:

* Assigned to work in a primary care specialty as a medical provider or assigned to work as a clinic pharmacist
* Assigned to work in one of the participating study clinics

Inclusion Criteria for Patients:

* Scheduled to be seen in a participating clinic with a physician or advanced practice provider in a primary care specialty or a clinic pharmacist
* Medical history of acute kidney injury during a hospitalization with discharge within 1 year before the scheduled appointment
* Medical history of type 2 diabetes mellitus (by billing code)
* Age 30 to 75 years at the date of study enrollment
* Available eGFR from labs more than 3 business days before the scheduled appointment and after AKI onset that is at least 30 mL/min/1.73 m²
* Either a serum creatinine lab measured after discharge from the hospitalization including the AKI, or the last serum creatinine lab during the hospitalization with AKI is less than 0.3 mg/dL above the patient's baseline serum creatinine concentration

Exclusion Criteria for Providers and Pharmacists:

* None

Exclusion Criteria for Patients:

* Opted out of research use of AHC/M Health Fairview data shelter data
* History of kidney transplantation as a recipient(by billing code)
* Pregnancy documented in AHC/M Health Fairview data shelter data (by billing code)
* SGLT2i allergy in the EHR allergy list
* Medical history of diabetic ketoacidosis, dementia, hospice care, or oncology care (by billing code and/or encounter)
* Medical history in the prior 1 year of indwelling Foley urinary catheter, cystitis, pyelonephritis, prostatitis, or urinary tract infection (by billing code)
* Serum creatinine rise of at least 0.3 mg/dL between the two most recent serum creatinine measurements
* Children
* Prisoners